Castellum, Viracta Therapeutics And 3 Stocks To Watch Heading Into Friday (CORRECTED)
Author: Avi Kapoor | December 27, 2024 03:35pm
Editor’s note: This story has been corrected to state that Castellum Inc — not Constellium SE — announced the pricing of a public stock offering.
With U.S. stock futures trading lower this morning on Friday, some of the stocks that may grab investor focus today are as follows:
- Viracta Therapeutics, Inc. (NASDAQ:VIRX) said its board has initiated a process to explore a broad range of strategic alternatives. The company announced plans to close its ongoing pivotal Phase 2 clinical trial of Nana-val in Relapsed/Refractory EBV + Lymphomas. Viracta Therapeutics shares dipped 13.9% to $0.2040 in the after-hours trading session.
- Evaxion Biotech A/S (NASDAQ:EVAX) applied for a patent for vaccines targeting Neisseria gonorrhoeae. Evaxion Biotech shares jumped 104.5% to $1.73 in after-hours trading.
- Castellum Inc (NYSE:CTM) announced the pricing of a previously announced stock offering of 4,355,000 shares at 85 cents per share for gross proceeds of approximately $3.7 million.
Check out our premarket coverage here.
- The Arena Group Holdings, Inc. (NASDAQ:AREN) disclosed that its compliance plan was accepted by the NYSE American. Arena Group shares jumped 17.6% to $1.67 in the after-hours trading session.
- Grid Dynamics Holdings, Inc. (NASDAQ:GDYN) will replace Revelyst Inc. (NYSE:GEAR) in the S&P SmallCap 600 effective before the opening bell on Thursday, Jan. 2. Grid Dynamics shares jumped 9.7% to $23.11 in after-hours trading.
Check This Out:
Photo courtesy: Wikimedia
Posted In: AREN CTM EVAX GDYN GEAR VIRX
